Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Reimbursement News » Palmetto Providing Limited Coverage for Single-Gene, Multi-Gene PGx Tests

Palmetto Providing Limited Coverage for Single-Gene, Multi-Gene PGx Tests

Jun 11, 2020
|
staff reporter

NEW YORK – Medicare Administrative Contractor Palmetto GBA released a final local coverage determination offering limited coverage for single-gene and multi-gene pharmacogenomics tests as a medical decision-making tool.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Reimbursement News

  1. Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.